BLAINJECTIONINJECTABLEPriority Review
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VITRASE is an ovine-derived hyaluronidase injectable enzyme approved in 2004 for facilitating dispersion and absorption of injected drugs and fluids. It works by breaking down hyaluronic acid in the extracellular matrix, enabling better penetration of co-administered therapeutic agents. The product serves as an adjunctive agent to enhance drug delivery in ophthalmic and other clinical settings.
LOE Approaching
LOE-approaching product with limited commercial runway; brand team likely focused on lifecycle extension and defending remaining market share against generic entry.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (7)
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
Started Jul 2005
10 enrolled
Vitreous DetachmentDiabetic Retinopathy
Evaluation of Vitrase as a Spreading Agent
Started Oct 2004
108 enrolled
Pain
Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics
Started Sep 2004
40 enrolled
Pain
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
Started Jul 2004
65 enrolled
Drug Hypersensitivity
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
Started Mar 2004
65 enrolled
Drug Hypersensitivity
Worked on VITRASE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.